TCR Engineered T Cell Therapy is an advanced form of immunotherapy designed to treat cancer by genetically modifying a patient's T cells to express specific T cell receptors (TCRs). These TCRs enable the T cells to recognize and attack cancer cells with greater precision. This therapy aims to harness the body's immune system to target and eliminate cancerous cells more effectively.